Biological Activity
IPI-145, also known as INK-1197, is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities.
Targets
Target | Value |
---|---|
PI3Kδ | ki: 23pM |
PI3Kγ | ki: 243pM |
PI3Kδ | ki: 23pM |
PI3Kβ | ki: 1564pM |
PI3Kα | ki: 25900pM |
PI3Kγ | ki: 243pM |
In vitro (25°C) | DMSO | 84 mg/mL (201.5 mM) | |
Water | <1 mg/mL (<1 mM) | ||
Ethanol | <1 mg/mL (<1 mM) | ||
In vivo | 30% PEG400/0.5% Tween80/5% propylene glycol | 30 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.99 mL | 119.94 mL | 239.89 mL |
0.5 mM | 4.8 mL | 23.99 mL | 47.98 mL |
1 mM | 2.4 mL | 11.99 mL | 23.99 mL |
5 mM | 0.48 mL | 2.4 mL | 4.8 mL |
*The above data is based on the productmolecular weight 416.86. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A12422 |
---|---|
Actions | Inhibitor |
M. Wt | 416.86 |
Formula | C22H17ClN6O |
Solubility | DMSO |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1201438-56-3 |
Synonyms | IPI145; IPI 145; IPI-145. INK-1197; INK 1197; INK1197 |
SMILES | C[[email protected]@H](C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 |
Datasheet
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy IPI-145 (Duvelisib, INK1197) | IPI-145 (Duvelisib, INK1197) Supplier | purchase | cost | manufacturer | order | distributor | buy 1201438-56-3| 1201438-56-3 Supplier | purchase 1201438-56-3 | 1201438-56-3 cost | 1201438-56-3 manufacturer | order 1201438-56-3 | 1201438-56-3 distributor